The Influence of Desensitizing Agent on Postoperative Sensitivity in Posterior Composite Restoration

NCT ID: NCT06113874

Last Updated: 2023-11-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-07-05

Study Completion Date

2023-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to investigate the influence of desensitizing agents on reducing post-operative sensitivity in posterior composite.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dentin Hypersensitivity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SEQUENTIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Composite with Hurriseal desensitizer

Group Type EXPERIMENTAL

Hurriseal desensitizer

Intervention Type OTHER

Patients will receive Hurriseal desensitizing agent and universal bond and composite.

Cavities will be restored with light-cured composite resin following the application of bonding agent.

Composite with Gluma Desensitizer

Group Type ACTIVE_COMPARATOR

Gluma desensitizer

Intervention Type OTHER

Patients will receive Gluma desensitizing agent and universal bond and composite.

Cavities will be restored with light-cured composite resin following the application of bonding agent.

Composite without desensitizer

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hurriseal desensitizer

Patients will receive Hurriseal desensitizing agent and universal bond and composite.

Cavities will be restored with light-cured composite resin following the application of bonding agent.

Intervention Type OTHER

Gluma desensitizer

Patients will receive Gluma desensitizing agent and universal bond and composite.

Cavities will be restored with light-cured composite resin following the application of bonding agent.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients having active primary class I carious lesions on vital molar teeth either in the middle or the inner third of dentin in the three quadrants of each patients.
* Teeth having a positive reaction to vitality test (cold test), no signs of pulp inflammation, or spontaneous pain before treatment.
* Preoperative radiographic record of the carious lesions.
* Buccolingual width is no more than half the inter-cuspal distance

Exclusion Criteria

* Excessive tooth wear due to clenching or abnormal habits.
* Patients with direct occlusal contact by antagonist cusp (traumatic occlusion).
* Patients with periodontal or gingival disease.
* Patients using analgesics and/or anti-inflammatory medicine.
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nourhan M.Aly

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nourhan M.Aly

Assistant Lecturer of Dental Public Health

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nessrin Magdy, BDS

Role: PRINCIPAL_INVESTIGATOR

Alexandria University

Waleed El-Mahy, PhD

Role: STUDY_DIRECTOR

Alexandria University

Rania R Afifi, PhD

Role: STUDY_CHAIR

Alexandria University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Dentistry, Alexandria University

Alexandria, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

7/22

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.